Switch View
© BusinessWire
22.09.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that five scientific presentations related to seralut...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer
News Preview
Incyte (Nasdaq:INCY) announces that Dave Gardner has been appointed Executive Vice President and Chief Strategy Officer (CSO) effective today, September 22, 2025. In his new role, Mr. Gardner will serve as a key member of the Executive Leadership Team and be responsible for the Company’s strategy and business development.
"Dave possesses a uniqu...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US71902K1051
CERo Therapeutics Holdings, Inc.
CERO
LISTED
NASDAQ
CERo Therapeutics Progresses Phase 1 CER-1236 AML Trial with Dosing of Third Patient in Initial Dose Cohort
News Preview
Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second dosing of second patient in the cohort...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
22.09.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress
News Preview
MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract reporting clinical data from the Phase 3 VIKTORIA-1 trial has been selected for an oral presentation at the upcoming European So...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
22.09.2025
ISIN: US59935P2092
Milestone Scientific Inc
MLSS
LISTED
XASE
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management
News Preview
Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the 45-day “window shop” period under the terms of the previously announced merger agreement with affiliates of Alcon (SIX/NYSE: ALC). The “window shop” peri...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
News Preview
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use
News Preview
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of innovative in vitro diagnostic technologies, is expanding its QUICKVUE portfolio with the QUICKVUE Influenza + SARS Test, a CLIA-waived, 510(k)–cleared rapid...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Aetna Expands Clinical Collaboration Program to Enhance Support for Hospitals and Provide Personalized Member Care
News Preview
Aetna Clinical Collaboration Program on-track to implement in ten hospitals by end of 2025 Early indicators show high member engagement with program projected to reduce 30-day readmissions and length of hospital stay HARTFORD, Conn., Sept. 22, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced it will scale the Aetna...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
News Preview
—Data from Phase 2b Study of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Arterial Hypertension to be Presented at Late-Breaking ALERT Session—
—New Analysis from Phase 3 ASPEN Trial Examines Efficacy and Safety of Brensocatib in Japanese Patients with Non-Cystic Fibrosis Bronchiectasis by Reduction of Exacerbation History— ...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: CA39986R1064
Grown Rogue International Inc.
GRIN
LISTED
CSE
Grown Rogue Acquires the Minority Interest in Illinois Subsidiary
News Preview
Increases Ownership from 70% to 100% in Illinois Cultivation Project
MEDFORD, Ore., Sept. 22, 2025 /CNW/ - Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE: GRIN) (OTC: GRUSF), a flower-forward cannabis company combining craft values with disciplined execution, today announced it has completed the acquisition of the 30% minori...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
News Preview
Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal Insemination Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal Insemination...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
22.09.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, is teaming up with actor and horror icon Matthew Lillard to encourage people 45 and older to get screened for colorectal cancer—the nation’s second leading cause of cancer-related death.1
This press release features multimedia. View the full release...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results from the pivotal study of zilganersen in children and adults living with Alexander disease (AxD), a rare, progressive and often fatal neurological condition with no approved disease-modifying treatments. Zilganersen 50 mg demonstrated statistically significant and...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery
News Preview
FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the future, with an initial focus on a robotic solution that will enable patients to pic...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
News Preview
Pfizer Inc. (NYSE: PFE) and Metsera, Inc. (NASDAQ: MTSR) today announced the companies have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases. The acquisition brings deep expertise and a portf...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
News Preview
HOUSTON, Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced the appoint...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: GG00BD3FV870
Okyo Pharma Limited
OKYO
LISTED
LSE
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
News Preview
LONDON and NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, today announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CH0334081137
CRISPR Therapeutics AG
CRSP
LISTED
NASDAQ
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
News Preview
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics, a clinical stage biotech company developing innovative small...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US0044685008
Achieve Life Sciences, Inc.
ACHV
LISTED
NASDAQ
Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD
News Preview
New data address critical treatment gap for millions of Americans with COPD who face unique smoking cessation challenges New data address critical treatment gap for millions of Americans with COPD who face unique smoking cessation challenges...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US4579852082
Integra Lifesciences Holdings Corp
IART
LISTED
NASDAQ
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
News Preview
Dr. Raymond Turner is a board-certified endovascular neurosurgeon with more than 20 years of surgical practice Dr. Raymond Turner is a board-certified endovascular neurosurgeon with more than 20 years of surgical practice...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CA64119M1059
Netramark Holdings Inc
AIAI
LISTED
CSE
NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research
News Preview
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced a new collaboration focused on gliobl...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier, Inc. Announces Definitive Agreement to Be Acquired by Patient Square Capital in Transaction Valued at $2.6 Billion
News Preview
Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Company”), a leading technology-driven health care improvement company, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital (“Patient Square”).
Under the terms of the agreement, which has been unanimously approved by Premier’s Boa...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CA48213Y1079
Jushi Holdings Inc.
JUSH
LISTED
CSE
Jushi Holdings Inc. Announces Favorable Modifications to Existing Manassas, VA Mortgage
News Preview
Company received $4,000,000 of additional loan proceeds...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US0017441017
AMN Healthcare Services Inc
AMN
LISTED
NYSE
AMN Healthcare Launches $400.0 Million Offering of Senior Notes
News Preview
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031, subject to market and other conditions. The 2031 Notes will be guaranteed...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US21833P3010
Corbus Pharmaceuticals Holdings Inc
CRBP
LISTED
NASDAQ
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
News Preview
KOL Panel to Discuss Data from Dose Optimization Clinical Trial of CRB-701 KOL Panel to Discuss Data from Dose Optimization Clinical Trial of CRB-701...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
News Preview
Cosmos Health commences U.S. operations with its Sky Premium Life brand, supported by local manufacturing capabilities. Anticipates strong cash flow....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US15678C1027
Ceribell, Inc.
CBLL
LISTED
NASDAQ
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
News Preview
Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companies Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companies...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US0167441049
Allarity Therapeutics, Inc.
ALLR
LISTED
NASDAQ
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
News Preview
- Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian Cancer Patients receiving stenoparib/2X-121 twice daily...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR”) (NASDAQ:STAA), today announced its opposition to the Company’s proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms announced on August 5, 2025.
Yunqi Capital re...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
News Preview
Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of bemdaneprocel, an investigational cell therapy for PD. At the same time, first European participants have been randomized in REGENERATE-PD, a Phase II...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: AU000000SPL0
Starpharma Holdings Ltd
SPL
LISTED
ASX
Starpharma Announces a Collaboration and License Agreement with Genentech
News Preview
MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology company, today announced the signing of a collaboration and license agreement with Genentech, a member of the Roche Group, to develop potential cancer therapies that leverage Starpharma’s proprietary DEP® drug deli...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CA03835T3091
Aptose Biosciences Inc.
APTO
LISTED
NASDAQ
Aptose and Hanmi Pharmaceutical Extend Loan Agreement to Continue Development of Tuspetinib in Triplet Therapy for AML
News Preview
Aptose and Hanmi Pharmaceutical Extend Loan Agreement to Continue Development of Tuspetinib in Triplet Therapy for AML...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US45826J1051
Intellia Therapeutics Inc
NTLA
LISTED
NASDAQ
Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
News Preview
Longer-term data to be presented at the 5th International ATTR Amyloidosis Meeting for Patients and Doctors on September 25 highlighting up to three years of patient follow-up and additional insight into ATTRv-PN disease-relevant measures Longer-term data to be presented at the 5th International ATTR Amyloidosis Meeting for Patients and Doctors on...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
News Preview
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one late breaking clinical trials oral presentation, one oral presentation, and three poster sessions will be shared at the Heart Fail...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US98419J2069
XOMA Royalty Corp
XOMA
LISTED
NASDAQ
XOMA Royalty Declares Quarterly Preferred Stock Dividends
News Preview
XOMA Royalty announces October 2025 dividend...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US55287L1017
MBX Biosciences, Inc.
MBX
LISTED
NASDAQ
MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension
News Preview
Statistically significant responder rate achieved at 12 weeks with zero contribution from rescue therapy (PRN) and further improvement sustained in open-label extension (OLE)...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
News Preview
REYKJAVIK, ICELAND (September 22, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) has adopted a positive opinion recommending appro...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
News Preview
REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) has adopted a positive opinion rec...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Reports 50% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial
News Preview
POTOMAC, MD / ACCESS Newswire / September 22, 2025 / IGC Pharma, Inc. (NYSE American:IGC), a clinical-stage pharmaceutical company focused on therapies for Alzheimer's disease, today announced it has reached a key enrollment milestone of 50% for its ongoing Phase 2 CALMA clinical trial evaluating IGC-AD1 for the treatment of agitation in Alzheimer'...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. Introduces AI Breakthrough for Squamous Cell Carcinoma Detection
News Preview
MESA, ARIZONA / ACCESS Newswire / September 22, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a significant innovation in dermatological AI: a platform capable of detecting squamous cell carcinoma (SCC), the second most common skin cancer and a condition responsible for more than 15,000 deaths annually in the United States a...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
News Preview
REYKJAVIK, ICELAND and LONDON, UK (September 22, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital,...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
News Preview
REYKJAVIK, ICELAND and LONDON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US89377M1099
Transmedics Group Inc
TMDX
LISTED
NASDAQ
TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy
News Preview
Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program ("NOP") hubs in Italy to support utilization of TransMedics' Organ Care System ("OCS") perfusion technology and increase donor organ utilization for patients in need
TransMedics President and Chief Executive Officer, Waleed Hassanein, M.D., to discu...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US89377M1099
Transmedics Group Inc
TMDX
LISTED
NASDAQ
TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy
News Preview
Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program ("NOP") hubs in Italy to support utilization of TransMedics' Organ Care System ("OCS") perfusion technology and increase donor organ utilization for patients in need
TransMedics President and Chief Executive Officer, Waleed Hassanein, M.D., to discu...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
News Preview
Study demonstrated Ketamir-2 was safe and well tolerated at all dose levels, with a favorable safety and tolerability profile, with no severe or clinically significant adverse effects observed. The drug showed rapid and predictable absorption, a favorable duration of action supporting once-daily dosing, and no CNS side effects typically seen with k...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.09.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
BB Biotech to be included in the SPI ESG Index
News Preview
Media release as at September 22, 2025
BB Biotech to be included in the SPI ESG Index
BB Biotech AG announces that it will be included in the SPI ESG Index of the SIX Swiss Exchange as of today, September 22, 2025. This highlights the investment company’s long-standing commitment to responsible investing and sustainable corporate governance.
Dr.......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.09.2025
ISIN: CH1110760852
PolyPeptide Group AG
PPGN
LISTED
SIX
PolyPeptide Group achieves significant milestone in Malmö expansion project
News Preview
PolyPeptide Group
/ Key word(s): Expansion
PolyPeptide Group achieves significant milestone in Malmö expansion project
22.09.2025 / 07:00 CET/CEST
Media Release
PolyPeptide Group achieves significant milestone in Malmö expansion project
Baar, 22 September 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized, globa......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.09.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
BB Biotech wird in den SPI ESG Index aufgenommen
News Preview
Medienmitteilung vom 22. September 2025
BB Biotech wird in den SPI ESG Index aufgenommen
Die BB Biotech AG gibt bekannt, dass sie per heute, 22. September 2025 in den SPI ESG Index der SIX Swiss Exchange aufgenommen wird. Damit wird das langjährige Engagement der Investmentgesellschaft für verantwortungsbewusstes Investieren und nachhaltige Unter......
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Two International Proxy Advisory Firms Support the Governance Project Proposed by OSE Immunotherapeutics at the September 30th General Meeting
News Preview
Two International Proxy Advisory Firms Support the Governance Project Proposed by OSE Immunotherapeutics at the September 30th General Meeting...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
News Preview
Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III
News Preview
PARIS, FRANCE, 22 September 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the first aesthetic data (n=183) for glabellar lines with internally developed IPN10200, following Stage 1 of the multi-stage, ongoing Phase II LANTIC trial. Patients treated with IPN10200 showed a statistically significant improvement in response at Week 4 vs plac...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
News Preview
Allschwil, Switzerland – September 22, 2025Idorsia Ltd. (SIX: IDIA) announces that Simcere Pharmaceuticals Group Ltd (2096.HK, “Simcere”) has launched QUVIVIQ® (daridorexant) in China. QUVIVIQ, Idorsia’s dual orexin receptor antagonist, is indicated for the treatment of adult patients with insomnia characterized by difficulty falling asleep and/or...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Positive phase III results show Roche’s giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer
News Preview
Basel, 22 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the phase III evERA study evaluating investigational giredestrant in combination with everolimus in people with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer p...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
News Preview
Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
News Preview
Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: KYG0520K1094
Ascletis Pharma Inc.
1672
LISTED
HKSE
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
News Preview
- The gastrointestinal (GI) tolerability of ASC47 in combination with semaglutide was significantly better than placebo in combination with semaglutide (semaglutide monotherapy). The incidence of vomiting was 6.7% in ASC47 in combination with semaglutide group compared to 57.1% in the semaglutide monotherapy group.
- Ultra-long-...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: CNE100003F19
Wuxi Apptec Co., Ltd.
2359
LISTED
HKSE
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends
News Preview
SHANGHAI, Sept. 21, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, implemented its first interim dividend plan, distributing a total of RMB1.03 billion in cash...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US84763A1088
Spectrum Pharmaceuticals, Inc.
SPPI
LISTED
NASDAQ
SPPI Deadline: Rosen Law Firm Urges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the “Class Period”). The lead plaintiff process was reopened by the Court. S...
Themefolio
Profiler
Peergroup
© BusinessWire
21.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: TNDM) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or fail...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
